The CXCR4 antagonist plerixafor enhances the effect of rituximab in diffuse large B-cell lymphoma cell lines
Crossref DOI link: https://doi.org/10.1186/s40364-016-0067-2
Published Online: 2016-06-14
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reinholdt, Linn
Laursen, Maria Bach
Schmitz, Alexander
Bødker, Julie Støve
Jakobsen, Lasse Hjort
Bøgsted, Martin
Johnsen, Hans Erik
Dybkær, Karen